Magnetic resonance imaging of perfusion in rat cerebral 9L tumor after nicotinamide administration

被引:35
作者
Brown, SL [1 ]
Ewing, JR [1 ]
Kolozsvary, A [1 ]
Butt, S [1 ]
Cao, Y [1 ]
Kim, JH [1 ]
机构
[1] Henry Ford Hosp, Dept Radiat Oncol, Detroit, MI 48202 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1999年 / 43卷 / 03期
关键词
tumor blood flow; NMR; perfusion; nicotinamide;
D O I
10.1016/S0360-3016(98)00422-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To investigate the effect of nicotinamide on normal brain and 9L tumor blood Row in the rat using magnetic resonance imaging (MRI) and arterial spin tagging. Methods and Materials: Using MRI at 7 Tesla, measurements of blood perfusion were determined from two-dimensional maps of intracerebral 9L rat tumors and normal Fischer rat brains. The spatial and temporal influence of nicotinamide, 500 mg/kg i.p., on cerebral blood flow (CBF) was studied in normal brain and tumors between 5 and 21 days after tumor implantation, The MRI CBF measurements employed a variable tip-angle-gradient-recalled echo (VTA-GRE-CBF) readout of the magnetization of the tissue slice. The VTA-GRE-CBF required 8 minutes for a blood Row image with inplane resolution of 250 mu m x 500 mu m x 2 mm. Results: Normal brain blood Row decreased following the administration of nicotinamide. In contrast, tumor blood flow remained unaffected in the time following nicotinamide administration, Consequently, the blood flowing in the tumor relative to that in normal brain demonstrated a significant and selective increase in response to nicotinamide administration. Relative tumor blood flow increased at 10 minutes after nicotinamide injection compared with predrug levels and remained elevated for at least 1 hour. Conclusion: The results suggest that nicotinamide will not enhance radiosensitivity of brain tumors. The results support the use of nicotinamide to improve delivery of anticancer therapeutics through its ability to selectively increase tumor blood how relative to that in normal brain. (C) 1999 Elsevier Science Inc.
引用
收藏
页码:627 / 633
页数:7
相关论文
共 43 条
[1]  
BROWN SL, UNPUB CORRELATION CH
[2]  
BROWN SL, 1996, HYPERTHERMIC ONCOLOG, V2, P771
[3]   PHARMACOKINETICS AND TOLERANCE OF NICOTINAMIDE COMBINED WITH RADIATION-THERAPY IN PATIENTS WITH GLIOBLASTOMA-MULTIFORME [J].
CARTEI, F ;
DANESI, R ;
DUCCI, F ;
FATIGANTE, L ;
CACIAGLI, PG ;
DELTACCA, M ;
LADDAGA, M .
ACTA ONCOLOGICA, 1994, 33 (08) :969-973
[4]   NICOTINAMIDE PHARMACOKINETICS IN PATIENTS [J].
DRAGOVIC, J ;
KIM, SH ;
BROWN, SL ;
KIM, JH .
RADIOTHERAPY AND ONCOLOGY, 1995, 36 (03) :225-228
[5]  
DRAGOVIC J, 1996, HYPERTHERMIC ONCOLOG, V2, P768
[6]  
EWING JR, 1995, P 17 INT S CER BLOOD, V15, pS610
[7]  
EWING JR, 1995, P SOC MAGN RES, V2, P871
[8]   Carbogen and nicotinamide combined with unconventional radiotherapy in glioblastoma multiforme: A new modality treatment [J].
Fatigante, L ;
Ducci, F ;
Cartei, F ;
Colosimo, S ;
Marini, C ;
Prediletto, R ;
Danesi, R ;
Laddaga, M ;
DelTacca, M ;
Caciagli, P .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (03) :499-504
[9]   Nicotinamide inhibits inducible nitric oxide synthase mRNA in primary rat glial cells [J].
Fujimura, M ;
Tominaga, T ;
Yoshimoto, T .
NEUROSCIENCE LETTERS, 1997, 228 (02) :107-110
[10]   Assessment of tumor microcirculation: A new role of dynamic contrast MR imaging [J].
Griebel, J ;
Mayr, NA ;
deVries, A ;
Knopp, MV ;
Gneiting, T ;
Kremser, C ;
Essig, M ;
Hawighorst, H ;
Lukas, PH ;
Yuh, WTC .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 1997, 7 (01) :111-119